New hope for stubborn skin allergies when nothing else works
NCT ID NCT03935971
Summary
This study is testing whether the medication dupilumab can help control severe allergic contact dermatitis in people who haven't improved with standard treatments like avoiding allergens and using creams. Seventeen adult participants with confirmed, persistent skin reactions received dupilumab for 10 weeks. Researchers measured changes in skin severity, itch, sleep quality, and immune markers to see if the drug provides relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONTACT DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital, Department of Dermatology
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.